|   |   | 
Legal status
Patent in force
| (51) | INT.CL. | A61K 45/06 | (2006.01) | 
| C07C 309/19 | (2006.01) | ||
| C07D 487/06 | (2006.01) | ||
| C07C 57/145 | (2006.01) | ||
| A61K 31/55 | (2006.01) | 
| (11) | Number of the document | 2534153 | 
| (13) | Kind of document | T | 
| (96) | European patent application number | 11708094.5 | 
| Date of filing the European patent application | 2011-02-10 | |
| (97) | Date of publication of the European application | 2012-12-19 | 
| (45) | Date of publication and mention of the grant of the patent | 2016-09-21 | 
| (46) | Date of publication of the claims translation | 2016-12-12 | 
| (86) | Number | PCT/IB2011/050571 | 
| Date | 2011-02-10 | 
| (87) | Number | WO 2011/098971 | 
| Date | 2011-08-18 | 
| (30) | Number | Date | Country code | 
| 304277 P | 2010-02-12 | US | 
| (72) | 
                    
                    
                    
                    
                    BASFORD, Patricia, Ann, GB  
                    
                    
                    
                    
                    CAMPETA, Anthony, Michael, US  
                    
                    
                    
                    
                    GILLMORE, Adam, GB  
                    
                    
                    
                    
                    JONES, Matthew, Cameron, GB  
                    
                    
                    
                    
                    KOUGOULOS, Eleftherios, US  
                    
                    
                    
                    
                    LUTHRA, Suman, US  
                    
                    
                    
                    
                    WALTON, Robert, GB  | 
| (73) | Pfizer Inc.,
                235 East 42nd Street, New York, NY 10017,
                US | 
| (74) | Jurga PETNIŪNAITĖ,
                AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
                LT | 
| (54) | 8-Fluor-2-{4-[(metilamino}metil]fenil}-1,3,4,5-tetrahidro-6H-azepino[5,4,3-CD]indol-6-ono druskos ir polimorfai | 
| SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO}METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE | 
| Payment date | Validity (years) | Amount | |
| 2025-01-23 | 15 | 289.00 EUR | 
| 2026-02-10 |